NEW YORK, May 3 – Deltagen’s first quarter revenues rose to $2.5 million, compared to $286,000 for the first quarter of 2000.

The company attributed this surge to subscription revenue from its DeltaBase mammalian gene function database. Pfizer and GlaxoSmithkline both subscribed to the database in the latter part of 2000, and Deltagen has additional ongoing agreements with Schering-Plough and Merck.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.